These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15460900)

  • 41. Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.
    Sumitomo K; Shimizu E; Shinohara A; Yokota J; Sone S
    Int J Oncol; 1999 Jun; 14(6):1075-80. PubMed ID: 10339660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
    Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication.
    Chen QM; Bartholomew JC; Campisi J; Acosta M; Reagan JD; Ames BN
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):43-50. PubMed ID: 9576849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma.
    Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Hoshi Y; DeCaprio JA; Anderson KC
    Leukemia; 1997 Nov; 11(11):1957-63. PubMed ID: 9369432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Senescence and immortalization of human cells.
    Duncan EL; Wadhwa R; Kaul SC
    Biogerontology; 2000; 1(2):103-21. PubMed ID: 11707927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
    Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence.
    Natarajan E; Omobono JD; Guo Z; Hopkinson S; Lazar AJ; Brenn T; Jones JC; Rheinwald JG
    Am J Pathol; 2006 Jun; 168(6):1821-37. PubMed ID: 16723698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
    Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
    Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The INK4a/ARF tumor suppressor: one gene--two products--two pathways.
    Chin L; Pomerantz J; DePinho RA
    Trends Biochem Sci; 1998 Aug; 23(8):291-6. PubMed ID: 9757829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV.
    Vázquez-Vega S; Sánchez-Suárez LP; Contreras-Paredes A; Castellanos-Juárez E; Peñarroja-Flores R; Lizano-Soberón M; Andrade-Cruz R; García-Carrancá A; Benítez-Bribiesca L
    Cancer Biomark; 2010-2011; 8(6):341-50. PubMed ID: 22072122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma.
    Platt G; Carbone A; Mittnacht S
    Oncogene; 2002 Mar; 21(12):1823-31. PubMed ID: 11896614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells.
    Chai J; Charboneau AL; Betz BL; Weissman BE
    Cancer Res; 2005 Nov; 65(22):10192-8. PubMed ID: 16288006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [pRB, p53, p16INK4a, senescence and malignant transformation].
    Larsen CJ
    Bull Cancer; 2004 May; 91(5):399-402. PubMed ID: 15281278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control.
    Takahashi A; Ohtani N; Hara E
    Cell Div; 2007 Mar; 2():10. PubMed ID: 17343761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
    Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
    Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Replicative senescence revisited.
    Marcotte R; Wang E
    J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):B257-69. PubMed ID: 12084796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior.
    Nilsson K; Svensson S; Landberg G
    Mod Pathol; 2004 Dec; 17(12):1464-74. PubMed ID: 15257310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.